USP26
Basic information
Region (hg38): X:133023168-133097109
Links
Phenotypes
GenCC
Source:
- spermatogenic failure, X-linked, 6 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spermatogenic failure, X-linked, 6 | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Genitourinary | 36796361 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the USP26 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | |||||
missense | 28 | 10 | 40 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 30 | 19 | 5 |
Variants in USP26
This is a list of pathogenic ClinVar variants found in the USP26 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-133025483-T-C | Likely benign (Mar 01, 2022) | |||
X-133025506-C-A | not specified | Uncertain significance (May 27, 2022) | ||
X-133025575-A-C | not specified | Uncertain significance (Oct 25, 2024) | ||
X-133025597-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
X-133025607-C-T | not specified | Likely benign (Dec 20, 2023) | ||
X-133025639-C-T | not specified | Likely benign (Dec 10, 2024) | ||
X-133025748-G-C | Spermatogenic failure, X-linked, 6 | Pathogenic (Mar 16, 2023) | ||
X-133025764-C-A | not specified | Uncertain significance (Sep 16, 2021) | ||
X-133025825-T-C | Spermatogenic failure, X-linked, 6 | Pathogenic (Mar 16, 2023) | ||
X-133025894-G-A | Likely benign (Apr 01, 2022) | |||
X-133025991-C-T | not specified | Uncertain significance (Jan 05, 2022) | ||
X-133026023-T-C | not specified | Uncertain significance (Apr 22, 2022) | ||
X-133026081-T-A | not specified | Uncertain significance (Dec 10, 2024) | ||
X-133026081-T-C | not specified | Uncertain significance (Aug 15, 2023) | ||
X-133026128-C-T | not specified | Likely benign (Oct 04, 2024) | ||
X-133026133-T-C | USP26-related disorder | Benign (Dec 31, 2019) | ||
X-133026159-C-T | Likely benign (Sep 01, 2022) | |||
X-133026212-T-C | USP26-related disorder | Likely benign (May 10, 2022) | ||
X-133026227-G-A | not specified | Uncertain significance (Dec 05, 2022) | ||
X-133026229-G-C | USP26-related disorder | Likely benign (Mar 20, 2019) | ||
X-133026238-C-A | USP26-related disorder | Likely benign (Mar 20, 2019) | ||
X-133026245-G-A | Likely benign (Dec 31, 2019) | |||
X-133026267-C-G | not specified | Uncertain significance (Oct 06, 2021) | ||
X-133026287-T-C | not specified | Uncertain significance (Mar 12, 2024) | ||
X-133026334-A-G | Likely benign (Apr 02, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
USP26 | protein_coding | protein_coding | ENST00000511190 | 1 | 72479 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0837 | 321 | 317 | 1.01 | 0.0000224 | 6067 |
Missense in Polyphen | 44 | 67.513 | 0.65172 | 1490 | ||
Synonymous | -0.300 | 126 | 122 | 1.03 | 0.00000885 | 1681 |
Loss of Function |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | ||
East Asian | ||
Finnish | ||
European (Non-Finnish) | ||
Middle Eastern | ||
South Asian | ||
Other |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the ubiquitin-dependent proteolytic pathway in conjunction with the 26S proteasome (By similarity). Deubiquitinates the androgen receptor and regulates the androgen receptor signaling pathway. {ECO:0000250, ECO:0000269|PubMed:20501646}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Ub-specific processing proteases;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.0741
Intolerance Scores
- loftool
- 0.414
- rvis_EVS
- 0.46
- rvis_percentile_EVS
- 78.69
Haploinsufficiency Scores
- pHI
- 0.0911
- hipred
- N
- hipred_score
- 0.158
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.161
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Usp26
- Phenotype
Gene ontology
- Biological process
- G1/S transition of mitotic cell cycle;ubiquitin-dependent protein catabolic process;protein deubiquitination
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;protein binding;thiol-dependent ubiquitinyl hydrolase activity